Dr. Ahmed Abdul Azim, MD

Dr. Abdul Azim practices at Clinical Academic Building in Tinton Falls, New Jersey.

Dr. Abdul Azim's NPI, 1073922324, was assigned on August 11, 2014. Dr. Abdul Azim holds New Jersey license 25MA10846100.

Dr. Abdul Azim's primary practice is Clinical Academic Building, at 66 Gilbert W St, Tinton Falls, NJ 07701 in Monmouth County. The practice phone is (732) 235-7060.

Dr. Abdul Azim's primary practice is Clinical Academic Building in Tinton Falls, New Jersey. Dr. Abdul Azim is also affiliated with Robert Wood Johnson University Hospital. The medical group on file is Rutgers-RWJ Scleroderma Program. Dmand AI also links Dr. Abdul Azim to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abdul Azim practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Abdul Azim's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Abdul Azim is licensed in New Jersey.

CMS data shows 343 Medicare services from Dr. Abdul Azim across 8 procedure codes in 2024, for 121 Medicare patients. Medicare paid $29,917 for them.

CMS counts 121 Medicare patients who saw Dr. Abdul Azim in 2024. The largest group is 65 to 74, with 45 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 3.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abdul Azim's median patient age at 67, with 43% women.

In 2024, Dr. Abdul Azim wrote 248 Medicare Part D claims for 31 patients. 38% of them were for generic drugs. CMS names the drug for 163 of them, across 8 drugs with 11 or more claims each, at $410,151 in total drug cost. In 2023, CMS named 75 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Abdul Azim for performance year 2024, reported as part of a group. Dr. Abdul Azim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abdul Azim as offering telehealth.

Dmand AI links 9 papers to Dr. Abdul Azim, published from 2018 to 2025. 2023 was the busiest year, with 3. Dr. Abdul Azim has published most often in Antimicrob Steward Healthc Epidemiol. Dr. Abdul Azim's most frequent co-authors are Pinki J. Bhatt, MD, Tanaya Bhowmick, MD and Thomas Hong, MD.

CMS Open Payments shows 5 general payments to Dr. Abdul Azim from 4 drug and device companies from 2017 to 2023. Education make up the largest share, 53% of the total. Astellas Pharma US Inc paid the most, $179.